Home > Journals > Minerva Surgery > Past Issues > Minerva Surgery 2022 April;77(2) > Minerva Surgery 2022 April;77(2):95-100



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as



Minerva Surgery 2022 April;77(2):95-100

DOI: 10.23736/S2724-5691.21.08839-0


language: English

Breast conservative surgery and whole breast radiotherapy versus breast conservative surgery and IORT: surgical opinion

Alessandra INVENTO 1 , Sara MIRANDOLA 2, Giulia DEGUIDI 2, Luna CERNUSCO 3, Renzo MAZZAROTTO 3, Francesca PELLINI 2

1 Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy; 2 Unit of Breast Surgery, Ospedale Civile Maggiore, University Hospital of Verona, Verona, Italy; 3 Unit of Radiotherapy, Ospedale Civile Maggiore, University Hospital of Verona, Verona, Italy

BACKGROUND: To define the possibility of intraoperative radiation therapy (IORT)’s application on clinical practice and point out the problems observed by Verona Breast Unit.
METHODS: Among the patients of the Breast Unit at Azienda Ospedaliera Universitaria Integrata of Verona, treated between July 2015 and June 2017, were identified 459 patients undergoing breast conserving surgery for a carcinoma, followed by IORT in 77 cases or by Whole Breast Radiotherapy (WBRT) in 382 cases. The data of WBRT group were analyzed considering IORT eligibility criteria to identify a sub-group of eligible patients, for whom we evaluated the diagnostic process that had led to exclusion from IORT.
RESULTS: In WBRT group 184 patients (48%) had a ductal NOS infiltrating carcinoma, of which 64 cases (16.8%) were eligible for IORT. Other 79 patients of WBRT group (21%) presented DCIS, of which only 27 were in the American Society for Radiation Oncology “suitable” group for IORT. Considering the results of the preoperative exams, or rather needle biopsy and MRI scan, 55 patients of 64 (85.9%) resulted unsuitable for IORT, while nine patients (14.1%) could be eligible.
CONCLUSIONS: IORT’s major limits are: the restricted eligibility criteria, especially on histology; the need of a complete execution of preoperative exams and the technical limits of these exams. ASTRO suitable group, including small diameter, low-grade DCIS, might be used to extend the eligibility criteria. A multidisciplinary approach might improve the preoperative study, so the use of IORT in clinical practice.

KEY WORDS: Needle biopsy; Segmental mastectomy; Conservative treatment; Raadiotherapy

top of page